Literature DB >> 28819741

Signaling Pathways as Potential Therapeutic Targets in Hepatocarcinogenesis.

Yeliz Yılmaz1,2, Ayşim Güneş1, Hande Topel1,2, Neşe Atabey3,4.   

Abstract

Entities:  

Year:  2017        PMID： 28819741     DOI： 10.1007/s12029-017-9958-1

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  131 in total

1.  Increased MAPK expression and activity in primary human hepatocellular carcinoma.

Authors:  C M Schmidt; I H McKillop; P A Cahill; J V Sitzmann
Journal:  Biochem Biophys Res Commun       Date:  1997-07-09       Impact factor: 3.575

Review 2.  Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors.

Authors:  L E Kemp; B Mulloy; E Gherardi
Journal:  Biochem Soc Trans       Date:  2006-06       Impact factor: 5.407

3.  Liver cancer: still a long way to go.

Authors:  Jordi Bruix
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

4.  Requisite role of VEGF receptors in angiogenesis of hepatocellular carcinoma: a comparison with angiopoietin/Tie pathway.

Authors:  Dipok Kumar Dhar; Hiroyuki Naora; Akira Yamanoi; Takashi Ono; Hitoshi Kohno; Hiroki Otani; Naofumi Nagasue
Journal:  Anticancer Res       Date:  2002 Jan-Feb       Impact factor: 2.480

Review 5.  Targeting the HGF/c-MET pathway in hepatocellular carcinoma.

Authors:  Lipika Goyal; Mandar D Muzumdar; Andrew X Zhu
Journal:  Clin Cancer Res       Date:  2013-02-06       Impact factor: 12.531

6.  Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.

Authors:  Abby B Siegel; Emil I Cohen; Allyson Ocean; Deborah Lehrer; Alec Goldenberg; Jennifer J Knox; Helen Chen; Sean Clark-Garvey; Alan Weinberg; John Mandeli; Paul Christos; Madhu Mazumdar; Elizabeta Popa; Robert S Brown; Shahin Rafii; Jonathan D Schwartz
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

7.  Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein.

Authors:  Alla Arzumanyan; Vaishnavi Sambandam; Marcia M Clayton; Steve S Choi; Guanhua Xie; Anna Mae Diehl; Dae-Yeul Yu; Mark A Feitelson
Journal:  Cancer Res       Date:  2012-09-17       Impact factor: 12.701

Review 8.  Beyond DNA repair: DNA-PK function in cancer.

Authors:  Jonathan F Goodwin; Karen E Knudsen
Journal:  Cancer Discov       Date:  2014-08-28       Impact factor: 39.397

9.  Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.

Authors:  Armando Santoro; Lorenza Rimassa; Ivan Borbath; Bruno Daniele; Stefania Salvagni; Jean Luc Van Laethem; Hans Van Vlierberghe; Jörg Trojan; Frank T Kolligs; Alan Weiss; Steven Miles; Antonio Gasbarrini; Monica Lencioni; Luca Cicalese; Morris Sherman; Cesare Gridelli; Peter Buggisch; Guido Gerken; Roland M Schmid; Corrado Boni; Nicola Personeni; Ziad Hassoun; Giovanni Abbadessa; Brian Schwartz; Reinhard Von Roemeling; Maria E Lamar; Yinpu Chen; Camillo Porta
Journal:  Lancet Oncol       Date:  2012-11-20       Impact factor: 41.316

10.  Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase.

Authors:  D Nath; N J Williamson; R Jarvis; G Murphy
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285
View more
  1 in total

1.  High glucose induced c-Met activation promotes aggressive phenotype and regulates expression of glucose metabolism genes in HCC cells.

Authors:  Hande Topel; Ezgi Bağırsakçı; Yeliz Yılmaz; Ayşim Güneş; Gülsün Bağcı; Dehan Çömez; Erkan Kahraman; Peyda Korhan; Neşe Atabey
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.